SCHEMBL1561769

SCHEMBL1561769

N=C(N)NCS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681807 0.76
SCHEMBL28685473 0.75 ALOX15 (0.50)
SCHEMBL33972 0.75 ALOX15 (0.50)
Sulfuric Acid SCHEMBL28899531 0.74 TDP1 (0.36)
Arcaine SCHEMBL1999196 0.74 ALOX15 (0.70)
Sulfuric Acid SCHEMBL10783977 0.72 ALOX15 (0.68)
Sulfuric Acid SCHEMBL11501592 0.72 ALOX15 (0.68)
Sulfuric Acid SCHEMBL11277287 0.72 ALOX15 (0.68)
Sulfuric Acid SCHEMBL6049589 0.72 ALOX15 (0.47)
Sulfuric Acid SCHEMBL11815400 0.72 ALOX15 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130068784-A1 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2013-03-21 US claimed
EP-2091513-B1 EJECTION LIQUID AND EJECTION METHOD CANON KK (JP) 2011-04-06 EP claimed
US-20100069290-A1 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2010-03-18 US claimed
EP-2091513-A2 EJECTION LIQUID AND EJECTION METHOD Canon Kabushiki Kaisha (JP) 2009-08-26 EP claimed
WO-2008069012-A2 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2008-06-12 WO claimed
US-20200317976-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE MONASH UNIVERSITY (AU) 2020-10-08 US disclosed
EP-3458539-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE Monash University (AU) 2019-03-27 EP disclosed
CN-104341450-B A kind of synthesis of phosphocreatine derivative and pharmaceutical applications 北京健峤医药科技有限公司 2018-03-27 CN disclosed
WO-2017197438-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE MONASH UNIVERSITY (AU) 2017-11-23 WO disclosed
CN-104341450-A Synthesis and pharmaceutical application of sulfamide derivative FU YIQIU 2015-02-11 CN disclosed
US-20130068784-A1 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2013-03-21 US disclosed
WO-2012116080-A1 PREPARATION OF BICYCLIC GUANIDINE SALTS IN AN AQUEOUS MEDIA PPG INDUSTRIES OHIO, INC. (US) 2012-08-30 WO disclosed
US-20100069290-A1 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2010-03-18 US disclosed
EP-2091513-A2 EJECTION LIQUID AND EJECTION METHOD Canon Kabushiki Kaisha (JP) 2009-08-26 EP disclosed
WO-2008069012-A2 EJECTION LIQUID AND EJECTION METHOD CANON KABUSHIKI KAISHA (JP) 2008-06-12 WO disclosed
CN-1064351-C Substituted 2, 3-dihydroindenyleneacetylguanidines, method for the production thereof, use thereof as medicaments or use thereof as diagnostic agents and medicaments containing the same HOECHST AG (DE) 2001-04-11 CN disclosed
CN-1061648-C Antiarrhythmic and cardioprotective substituted indenoylguanidines HOECHST AG (DE) 2001-02-07 CN disclosed
CN-1172104-A Substituted 2, 3-dihydroindenyleneacetylguanidines, method for the production thereof, use thereof as medicaments or use thereof as diagnostic agents and medicaments containing the same HOECHST AG (DE) 1998-02-04 CN disclosed
CN-1140164-A Antiarrhythmic and cardioprotective substituted indenoylguanidines HOECHST AG (DE) 1997-01-15 CN disclosed
US-3943253-A Guanido acids as fungicides BARER SOL J 1976-03-09 US disclosed